Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein
- Author
- WALTHER, Michael1 ; THOMPSON, Fiona M1 ; POULTON, Ian1 ; DUBOVSKY, Filip3 ; TIERNEY, Eveline3 ; CORREA, Simon1 ; HUNTCOOKE, Angela1 ; BUTCHER, Geoffrey4 ; WILLIAMS, Jack5 ; SINDEN, Robert E4 ; HILL, Adrian V. S1 2 ; DUNACHIE, Susanna1 ; KEATING, Sheila1 ; TODRYK, Stephen1 ; BERTHOUD, Tamara1 ; ANDREWS, Laura2 ; ANDERSEN, Rikke F2 ; MOORE, Anne2 ; GILBERT, Sarah C2
[1] Centre for Clinical Vaccinology & Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Churchill Hospital, Oxford OX3 7LJ, United Kingdom
[2] The Wellcome Trust Centre for Human Genetics, Nuffield Department of Clinical Medicine, Oxford University, Roosevelt Drive, Oxford OX3 7BN, United Kingdom
[3] PATH Malaria Vaccine Initiative, Bethesda, Maryland 20814, United States
[4] Department of Biological Sciences, Sir Alexander Fleming Building, Imperial College London, Imperial College Road, London SW7 2AZ, United Kingdom
[5] Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, Maryland 20910, United States - Source
Infection and immunity. 2006, Vol 74, Num 5, pp 2706-2716, 11 p ; ref : 44 ref
- CODEN
- INFIBR
- ISSN
- 0019-9567
- Scientific domain
- Immunology, immunopathology, allergology; Microbiology, infectious diseases; Parasitology; Virology
- Publisher
- American Society for Microbiology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Efficacité Immunisation Immunité Immunogénicité Microbiologie Plasmodium falciparum Poxviridae Protéine Toxicité Vaccin Virus vaccine Apicomplexa Chordopoxvirinae Orthopoxvirus Protozoa Virus
- Keyword (en)
- Efficiency Immunization Immunity Immunogenicity Microbiology Plasmodium falciparum Poxviridae Protein Toxicity Vaccine Vaccinia virus Apicomplexa Chordopoxvirinae Orthopoxvirus Protozoa Virus
- Keyword (es)
- Eficacia Inmunización Inmunidad Inmunogenicidad Microbiología Plasmodium falciparum Poxviridae Proteína Toxicidad Vacuna Vaccinia virus Apicomplexa Chordopoxvirinae Orthopoxvirus Protozoa Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05F Applied microbiology / 002A05F04 Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
- Discipline
- Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17730688
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1128/IAI.74.5.2706-2716.2006 
https://dx.doi.org/10.1128/IAI.74.5.2706-2716.2006
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/IAI.74.5.2706-2716.2006\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Infection and immunity\";s:9:\"\u0000*\u0000stitle\";s:13:\"Infect. immun\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2716\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0019-9567\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WALTHER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:17:\"THOMPSON, Fiona M\";i:1;s:12:\"POULTON, Ian\";i:2;s:15:\"DUBOVSKY, Filip\";i:3;s:16:\"TIERNEY, Eveline\";i:4;s:13:\"CORREA, Simon\";i:5;s:17:\"HUNTCOOKE, Angela\";i:6;s:17:\"BUTCHER, Geoffrey\";i:7;s:14:\"WILLIAMS, Jack\";i:8;s:16:\"SINDEN, Robert E\";i:9;s:17:\"HILL, Adrian V. S\";i:10;s:17:\"DUNACHIE, Susanna\";i:11;s:15:\"KEATING, Sheila\";i:12;s:15:\"TODRYK, Stephen\";i:13;s:16:\"BERTHOUD, Tamara\";i:14;s:14:\"ANDREWS, Laura\";i:15;s:17:\"ANDERSEN, Rikke F\";i:16;s:11:\"MOORE, Anne\";i:17;s:16:\"GILBERT, Sarah C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"INFIBR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/IAI.74.5.2706-2716.2006\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Infection and immunity\";s:9:\"\u0000*\u0000stitle\";s:13:\"Infect. immun\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2716\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0019-9567\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WALTHER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:17:\"THOMPSON, Fiona M\";i:1;s:12:\"POULTON, Ian\";i:2;s:15:\"DUBOVSKY, Filip\";i:3;s:16:\"TIERNEY, Eveline\";i:4;s:13:\"CORREA, Simon\";i:5;s:17:\"HUNTCOOKE, Angela\";i:6;s:17:\"BUTCHER, Geoffrey\";i:7;s:14:\"WILLIAMS, Jack\";i:8;s:16:\"SINDEN, Robert E\";i:9;s:17:\"HILL, Adrian V. S\";i:10;s:17:\"DUNACHIE, Susanna\";i:11;s:15:\"KEATING, Sheila\";i:12;s:15:\"TODRYK, Stephen\";i:13;s:16:\"BERTHOUD, Tamara\";i:14;s:14:\"ANDREWS, Laura\";i:15;s:17:\"ANDERSEN, Rikke F\";i:16;s:11:\"MOORE, Anne\";i:17;s:16:\"GILBERT, Sarah C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"INFIBR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/IAI.74.5.2706-2716.2006\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/IAI.74.5.2706-2716.2006\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Infection and immunity\";s:9:\"\u0000*\u0000stitle\";s:13:\"Infect. immun\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2716\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0019-9567\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WALTHER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:17:\"THOMPSON, Fiona M\";i:1;s:12:\"POULTON, Ian\";i:2;s:15:\"DUBOVSKY, Filip\";i:3;s:16:\"TIERNEY, Eveline\";i:4;s:13:\"CORREA, Simon\";i:5;s:17:\"HUNTCOOKE, Angela\";i:6;s:17:\"BUTCHER, Geoffrey\";i:7;s:14:\"WILLIAMS, Jack\";i:8;s:16:\"SINDEN, Robert E\";i:9;s:17:\"HILL, Adrian V. S\";i:10;s:17:\"DUNACHIE, Susanna\";i:11;s:15:\"KEATING, Sheila\";i:12;s:15:\"TODRYK, Stephen\";i:13;s:16:\"BERTHOUD, Tamara\";i:14;s:14:\"ANDREWS, Laura\";i:15;s:17:\"ANDERSEN, Rikke F\";i:16;s:11:\"MOORE, Anne\";i:17;s:16:\"GILBERT, Sarah C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"INFIBR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/IAI.74.5.2706-2716.2006\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Infection and immunity\";s:9:\"\u0000*\u0000stitle\";s:13:\"Infect. immun\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2716\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0019-9567\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WALTHER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:17:\"THOMPSON, Fiona M\";i:1;s:12:\"POULTON, Ian\";i:2;s:15:\"DUBOVSKY, Filip\";i:3;s:16:\"TIERNEY, Eveline\";i:4;s:13:\"CORREA, Simon\";i:5;s:17:\"HUNTCOOKE, Angela\";i:6;s:17:\"BUTCHER, Geoffrey\";i:7;s:14:\"WILLIAMS, Jack\";i:8;s:16:\"SINDEN, Robert E\";i:9;s:17:\"HILL, Adrian V. S\";i:10;s:17:\"DUNACHIE, Susanna\";i:11;s:15:\"KEATING, Sheila\";i:12;s:15:\"TODRYK, Stephen\";i:13;s:16:\"BERTHOUD, Tamara\";i:14;s:14:\"ANDREWS, Laura\";i:15;s:17:\"ANDERSEN, Rikke F\";i:16;s:11:\"MOORE, Anne\";i:17;s:16:\"GILBERT, Sarah C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"INFIBR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/IAI.74.5.2706-2716.2006\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Infection and immunity\";s:9:\"\u0000*\u0000stitle\";s:13:\"Infect. immun\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"74\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"2706\";s:8:\"\u0000*\u0000epage\";s:4:\"2716\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0019-9567\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WALTHER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:17:\"THOMPSON, Fiona M\";i:1;s:12:\"POULTON, Ian\";i:2;s:15:\"DUBOVSKY, Filip\";i:3;s:16:\"TIERNEY, Eveline\";i:4;s:13:\"CORREA, Simon\";i:5;s:17:\"HUNTCOOKE, Angela\";i:6;s:17:\"BUTCHER, Geoffrey\";i:7;s:14:\"WILLIAMS, Jack\";i:8;s:16:\"SINDEN, Robert E\";i:9;s:17:\"HILL, Adrian V. S\";i:10;s:17:\"DUNACHIE, Susanna\";i:11;s:15:\"KEATING, Sheila\";i:12;s:15:\"TODRYK, Stephen\";i:13;s:16:\"BERTHOUD, Tamara\";i:14;s:14:\"ANDREWS, Laura\";i:15;s:17:\"ANDERSEN, Rikke F\";i:16;s:11:\"MOORE, Anne\";i:17;s:16:\"GILBERT, Sarah C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"INFIBR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus ankara encoding the full-length Plasmodium falciparum circumsporozoite protein\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
